Inside the research
Balchem Corporation
BCPC Research profile · latest available data
Price overview
$167.89
▲ +0.05 (+0.0%)
| 52w hi | $183.26 |
|---|---|
| 52w lo | $139.44 |
| Vol | 212.50K |
| As of | 25 Sep 2026 |
The Verdict
Our score -0.13
| Short | -0.11 |
|---|---|
| Medium | -0.18 |
| Long | -0.08 |
computed 2026-09-27
Key fundamentals
Balchem Corporation
Basic Materials · Specialty Chemicals
| Market cap | $5.35B |
|---|---|
| Enterprise value | $5.46B |
| Trailing P/E | 32.98x |
| Forward P/E | 26.77x |
| EV / EBITDA | 20.25x |
| P / S (ttm) | 4.93x |
| Profit margin | 15.1% |
| Return on equity | 12.8% |
| Revenue growth | +11.2% |
| Earnings growth | +18.8% |
| Debt / equity | 12.80 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.23 | |
| Sector | -0.02 | |
| Technical | -0.12 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.
Risk Metrics
| Beta vs SPX | 0.49 |
|---|---|
| Corr SPX | 0.36 |
| Annual vol | 21.6% |
| Annual ret | +0.3% |
| Sharpe | 0.02 |
| Max DD | -23.5% |
Window: 504 trading days (504 obs)
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-07-31 | Earnings Release, Exhibits | read |
| 2026-07-27 | Material Agreement, Material Obligation… | read |
| 2026-06-22 | Shareholder Vote | read |
| 2026-04-30 | Earnings Release, Exhibits | read |
| 2026-02-20 | Earnings Release, Exhibits | read |
| 2026-02-19 | Officer / Director Change, Exhibits | read |
| 2025-12-10 | Reg FD Disclosure, Exhibits | read |
| 2025-10-21 | Earnings Release, Exhibits | read |
| 2025-07-31 | Earnings Release, Exhibits | read |
| 2025-06-20 | Shareholder Vote | read |
| 2025-04-24 | Earnings Release, Exhibits | read |
| 2025-03-03 | Officer / Director Change, Exhibits | read |
Flow & Concentration
| Insider 180d net | $0 |
|---|---|
| Insider buys / sells | 0 / 0 |
| Insider bias | Neutral |
| 13F holders | 9 |
| Top-5 share | 94.0% |
| HHI | 3,428 (concentrated) |
Top Holders
| Holder | Value | Shares |
|---|---|---|
| State Street Corp | $216.52M | 1.28M |
| Fidelity / FMR LLC | $94.66M | 560.25K |
| Renaissance Technologies | $32.66M | 193.30K |
| Millennium Management | $31.18M | 184.56K |
| AQR Capital Management | $12.58M | 74.43K |
| Citadel Advisors | $12.51M | 74.02K |
| Capital Research / Capital World | $9.95M | 58.92K |
| Bridgewater Associates | $2.27M | 13.42K |
| T. Rowe Price Group | $18.82K | 111.37K |
As of 2026-06-30
Dividends
| Yield (TTM) | 0.57% |
|---|---|
| $ / share (TTM) | $0.96 |
| 5y CAGR | +10.6% |
Annual dividend per share
| 2020 | $0.58 |
|---|---|
| 2021 | $0.64 |
| 2022 | $0.71 |
| 2023 | $0.79 |
| 2024 | $0.87 |
| 2025 | $0.96 |
SEC Filings
The Long Run
FY 2011–2025 · 15 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $234.08M | +8.7% | |
| Gross profit | $93.11M | +2.4% | |
| Operating income | $182.91M | +8.8% | |
| Net income | $108.54M | +7.6% | |
| Cash from ops | $183.76M | +13.0% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $167.41 | $168.59 | $166.01 | $167.89 | 212.50K |
| Sep 24 | $168.94 | $169.16 | $166.91 | $167.84 | 159.40K |
| Sep 23 | $167.65 | $169.51 | $167.65 | $168.24 | 145.60K |
| Sep 22 | $169.58 | $170.62 | $167.99 | $168.40 | 217.00K |
| Sep 21 | $167.73 | $168.34 | $166.08 | $167.34 | 199.00K |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →